-+ 0.00%
-+ 0.00%
-+ 0.00%

Bambusa Therapeutics Director Helmut Wolfgang Jeggle Reports $6 Million Common Share Acquisition

PUBT·11/02/2026 21:07:05
Listen to the news
Bambusa Therapeutics Director Helmut Wolfgang Jeggle Reports $6 Million Common Share Acquisition
  • Bambusa Therapeutics director Helmut Wolfgang Jeggle purchased 375,000 common shares at $16 each.
  • Indirect common stock holdings reached 9,264,301 shares, including 4,769,701 shares acquired through preferred stock conversion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bambusa Therapeutics, Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001982614-26-000004), on November 02, 2026, and is solely responsible for the information contained therein.